Aug 31 (Reuters) - Vectus Biosystems Ltd (VBS) FY revenues from ordinary activities down 35 percent to $49,000 FY loss for period attributable to members $3.8 million
The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint